Zhang X, Yang Y, Liu B, Du X, Wang X, Zhu H, Yu L, Li Z, Zhao S, Yang L, Ma Y, Meng L, Zhang Y, Li G, Yang L, Wang B, Ran X, Huang J, Gao N, Wen Q, Wen Y, Zhao Y, Zhu Y, Han Y, Liu Z, Du X, Weng J, Gale RP, Zhou L, Zhang Y, Jiang Q. Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia. Haematologica 2025;110(12):2986-2996; https://doi.org/10.3324/haematol.2024.287116.